Dr. Vinay Kumar Gupta, MD

Dr. Vinay Kumar Gupta, MD

Languages: English, Hindi
Fax: (855) 778-6856

Contact this Provider:

 (443) 777-7911
Specialties
  • Surgical Oncology
Conditions I Treat
  • acral lentiginous melanoma
  • axillary lymphadenectomy
  • biliary colic
  • cholecystitis
  • colonic volvulus
    • Show All
Procedures I Perform
  • abdominal surgery
  • appendectomy
  • breast biopsy
  • breast cancer surgery
  • cholecystectomy
    • Show All
About the Provider

Dr. Gupta is a fellowship-trained surgical oncologist providing consultation and surgical expertise at Franklin Square Medical Center and Good Samaritan Hospital.

He specializes in cancers of the pancreas, liver, stomach, colon and rectum, breast, as well as soft tissue sarcomas and melanoma.

He received his medical degree from the University of Maryland, completed his general surgery residency at the Medical College of Georgia and completed his fellowship in surgical oncology at the University of Chicago Hospitals. He also serves as cancer liaison physician for the American College of Surgeons Commission on Cancer. Additionally, he teaches our future surgeons as Associate Program Director of the general surgery residency program at MedStar Health Baltimore.

Vinay Gupta, MD, was named 2017 and 2018 "Top Doc" by Baltimore Magazine for surgical oncology.  He has consistently received excellent reviews from patients and his peers.

Videos
Education
  • Fellowship Program: University of Chicago Medical Center (2002)
  • Residency Program: Medical College of Georgia Hospital (1999)
  • Internship Program: Medical College of Georgia Hospital (1994)
  • Medical School: University of Maryland School of Medicine (1993)
  • Board Certification: American Board of Surgery, Surgery
Publications
  1. AbdusSamad M, Gaur A, Zhou H, Zapas JL, Gupta VK, Simbulan-Rosenthal CM, McCarron EC, Rosenthal DS. Combination therapy with mebendazole, trametinib and metformin eliminates recalcitrant NRAS mutant, BRAF wild type melanoma cells. American Association of Cancer Research, Abstract, 2015.
  2. Heitmiller RF and Gupta VK. Apprenticeship: Preserving the Commitment to Surgical Education. Journal of Surgical Education 65(4):259-262, 2008.
  3. Gupta VK and Heitmiller RF. Union Memorial Hospital: An Insight to the Origin of Community based Surgical Training. Journal of Surgical Education 65(2):162-165, 2008.
  4. Gupta VK, Park JO, Kurihara T, Koons A, Jaskowiak NT, Kufe DW, Weichselbaum RR, Posner MC. Selective gene expression in a human esophageal adenocarcinoma model using a DF3/MUC1 promoter. Gene Therapy 10(3):206-212, 2003.
  5. Mauceri HJ, Seetharam S, Beckett MA, Schumm LP, Koons A, Gupta VK, Park JO, Manan A, Lee JY, Montag AG, Kufe DW, Weichselbaum RR. Angiotensin potentiates cyclophosphamide treatment of metastatic disease. Cancer Chemotherapy & Pharmacology 50(5):412-418, 2002.
  6. Park JO, Lopez CA, Gupta VK, Brown CK, Mauceri HJ, Dara TE, Manan A, Hellman S, Posner MC, Kufe DW, Weichselbaum RR. Transcriptional control of viral gene therapy by cisplatin. Journal of Clinical Investigation 110(3):403-410, 2002.
  7. Gupta VK, Park JO, Jaskowiak NT, Mauceri HJ, Seetharam S, Kufe DW, Weichselbaum RR, Posner MC. Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma. Annals of Surgical Oncology 9(5):500-504, 2002.
  8. Gupta VK, Jaskowiak NT, Becket MA, Mauceri HJ, Grunstein J, Johnson RS, Calvin DA, Nodzenski E, Pejovic M, Kufe DW, Posner MC, Weichselbaum RR. Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. The Cancer Journal, Scientific American 8(1):47-54, 2002.
  9. Mauceri HJ, Seetharam S, Beckett MA, Lee JY, Gupta VK, Gately S, Stack MS, Brown CK, Swedberg K, Kufe DW, Weichselbaum RR. Tumor production of angiostatin is enhanced following exposure to TNF alpha. International Journal of Cancer 97(4):410-415, 2002.
  10. Salloum RM, Jaskowiak NT, Mauceri HJ, Seetharam S, Beckett MA, Koons AM, Hari DM, Gupta VK, Reimer C, Kalluri R, Posner MC, Hellman S, Kufe DW, Weichselbaum RR. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Research 60:6958-6963, 2000.
  11. Gupta VK, Yeh KA, Burke GJ, Wei JP. 99m-Tc sestamibi localized solitary parathyroid adenoma as an indication for limited unilateral surgical exploration. The American Journal of Surgery 176:409-412, 1998.
  12. Howdieshell TR, Riegner C, Gupta VK, McNeil PL. Normoxic wound fluid contains high levels of vascular endothelial growth factor. Annals of Surgery 228(5):707-715, 1998.
  13. Gupta VK, McNeil PL, Reigner C, Howdieshell TR. Vascular endothelial growth factor is a key mediator of omental angiogenesis. Surgical Forum, 82nd Annual Clinical Congress 157:746-748, 1996.
  14. Midis GP, Gupta VK, Fabian DF, Lefor AT. Target cell membrane modification and susceptibility to lymphokine activated killer cell mediated lysis II. Sodium periodate has a differential effect on the lysis of human and murine tumor cells. Journal of Surgical Research 56:146-154, 1994.
  15. Gupta VK, Midis GP, Fabian DF, Lefor AT. Sodium periodate has a differential effect on the human and murine LAK cell mediated lysis. FASEB Journal 6:A1151, 1992.
  16. Midis GP, Gupta VK, Fabian DF, Lefor AT. Combined-modality therapy for murine subcutaneous tumors with immunotherapy and hyperthermia. Current Surgery 488:456-457, 1991.
Insurance

Practice Locations
  • 9103 Franklin Square Drive
    Floor 2
    Baltimore, MD 21237
    View Map

  • 5601 Loch Raven Boulevard
    GSH SMYTH BUILDING
    Suite G1
    Baltimore, MD 21239
    View Map

  • 5601 Loch Raven Boulevard
    GOOD SAMARITAN HOSPTIAL
    Baltimore, MD 21239
    View Map

Member of Medical Staff
Awards
  • Baltimore Magazine Top Doctor, 2015-2018
  • Maryland State Chair, American College of Surgeons Commission on Cancer, 2012-2018
  • Vice Chair, Georgetown University Oncology Institutional Review Board  2009-2012
  • Georgetown University Oncology Institutional Review Board  2006-2009